Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Für diesen Artikel ist leider kein Bild verfügbar.

Diagnosing and Treating Adult Cancers and Associated Impairments

Buch | Softcover
374 Seiten
2021
National Academies Press (Verlag)
978-0-309-68400-2 (ISBN)
CHF 113,45 inkl. MwSt
  • Versand in 10-15 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
Cancer is the second leading cause of death among adults in the United States after heart disease. However, improvements in cancer treatment and earlier detection are leading to growing numbers of cancer survivors. As the number of cancer survivors grows, there is increased interest in how cancer and its treatments may affect a person's ability to work, whether the person has maintained employment throughout the treatment or is returning to work at a previous, current, or new place of employment. Cancer-related impairments and resulting functional limitations may or may not lead to disability as defined by the U.S. Social Security Administration (SSA), however, adults surviving cancer who are unable to work because of cancer-related impairments and functional limitations may apply for disability benefits from SSA.


At the request of SSA, Diagnosing and Treating Adult Cancers and Associated Impairments provides background information on breast cancer, lung cancer, and selected other cancers to assist SSA in its review of the listing of impairments for disability assessments. This report addresses several specific topics, including determining the latest standards of care as well as new technologies for understanding disease processes, treatment modalities, and the effect of cancer on a person's health and functioning, in order to inform SSA's evaluation of disability claims for adults with cancer.

Table of Contents


Front Matter
Summary
1 Introduction
2 The U.S. Social Security Administration Disability Process
3 Cancer Epidemiology
4 Diagnosis, Staging, and Treatment of Cancer
5 Breast Cancer
6 Lung Cancer
7 Selected Topics in Other Cancers
8 New and Emerging Therapies
9 Cancer-Related Impairments Leading to Functional Limitations
10 Survivorship Outcomes and Care Delivery
Appendix A: Biographical Sketches of Committee Members and Consultant
Appendix B: Public Session Agendas
Erscheinungsdatum
Verlagsort Washington
Sprache englisch
Maße 152 x 229 mm
Themenwelt Medizin / Pharmazie Gesundheitswesen
Medizin / Pharmazie Medizinische Fachgebiete Onkologie
ISBN-10 0-309-68400-5 / 0309684005
ISBN-13 978-0-309-68400-2 / 9780309684002
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
CHF 37,80
Resilienz innovativ stärken : ein Praxishandbuch

von Christa Diegelmann; Margarete Isermann; Tanja Zimmermann

Buch | Softcover (2023)
Kohlhammer (Verlag)
CHF 49,95